Cargando…
Clinical prospects of WRN inhibition as a treatment for MSI tumours
The discovery of synthetic lethal interactions with genetic deficiencies in cancers has highlighted several candidate targets for drug development, with variable clinical success. Recent work has unveiled a promising synthetic lethal interaction between inactivation/inhibition of the WRN DNA helicas...
Autores principales: | Morales-Juarez, David A., Jackson, Stephen P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9666358/ https://www.ncbi.nlm.nih.gov/pubmed/36379964 http://dx.doi.org/10.1038/s41698-022-00319-y |
Ejemplares similares
-
The interaction site of Flap Endonuclease-1 with WRN helicase suggests a coordination of WRN and PCNA
por: Sharma, Sudha, et al.
Publicado: (2005) -
Acetylation of WRN Protein Regulates Its Stability by Inhibiting Ubiquitination
por: Li, Kai, et al.
Publicado: (2010) -
Unraveling the roles of WRN and DNA-PKcs at telomeres
por: Beattie, Tara L., et al.
Publicado: (2010) -
CDK2 phosphorylation of Werner protein (WRN) contributes to WRN’s DNA double‐strand break repair pathway choice
por: Lee, Jong‐Hyuk, et al.
Publicado: (2021) -
Colorectal Carcinogenesis: MSI-H Versus MSI-L
por: Pawlik, Timothy M., et al.
Publicado: (2004)